1. OC-0257 Impact of RT dose and fractionation on biomarkers of systemic immune responses in early stage NSCLC. (May 2022) Authors: Gkika, E.; Firat, E.; Adebahr, S.; Popp, I.; Radicioni, G.; Exner, J.; Rühle, A.; Sprave, T.; Nestle, U.; Nicolay, N.; Niedermann, G.; Duda, D.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-0874 Impact of dose and prescription method in SBRT of NSCLC. A pooled analysis of 2 prospective trials. (August 2021) Authors: Gkika, E.; Adebahr, S.; Radicioni, G.; Exner, J.; Haehl, E.; Spohn, S.; Rühle, A.; Zamboglou, C.; Nicolay, N.; Sprave, T.; Wiehle, R.; Baltas, D.; Nestle, U.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗